EICHORCondition: Major Depressive Disorder · Sponsor: Shire
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This study is an optional continuation of previous short-term adult major depressive disorder (MDD) augmentation studies. Patients may only take part in this long-term, open-label research study if they completed a previous double-blind MDD augmentation study using SPD489.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Subject has completed 1 of the respective short-term antecedent SPD489 MDD studies and did not experience any clinically significant AEs in the antecedent study that would preclude exposure to SPD489. Exclusion Criteria: * Subject has any current co-morbid Axis I or Axis II psychiatric disorder (including a lifetime history of psychosis) which was not present or recognized at entry into the antecedent study or has a concurrent chronic or acute illness or unstable medical condition that may deteriorate that could confound the results of safety assessments, increase risk to the subject or lead to difficulty complying with the protocol
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Birmingham Research Group | Birmingham, Alabama, United States | — |
| ResearchOne, Inc. | Scottsdale, Arizona, United States | — |
| Arkansas Psychiatric Clinical Research Trials, P.A. | Little Rock, Arkansas, United States | — |
| South Coast Clinical Trials, Inc. | Anaheim, California, United States | — |
| American Neuropsychiatric Research, Inc. | Carson, California, United States | — |
| Catalina Research Institute, LLC | Chino, California, United States | — |
| Shanti Clinical Trials | Colton, California, United States | — |
| ATP Clinical Research | Costa Mesa, California, United States | — |
| Clinical Innovation, Inc. | Costa Mesa, California, United States | — |
| Diligent Clinical Trials | Downey, California, United States | — |
| Synergy Clinical Research Center of Escondido | Escondido, California, United States | — |
| Collaborative Neuroscience Network, Inc. | Garden Grove, California, United States | — |
+ 200 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01436175